Micron (NASDAQ:MU) is riding one of the market’s most exciting AI memory stories, but its Virginia expansion points to a broader opportunity. The company isn’t just chasing data center demand. It’s also targeting industries that need reliable long-term memory supply, including defense, automotive, aerospace, industrial equipment, and medical devices. Stock prices used were the market … Read more
Advanced Micro Devices (NASDAQ:AMD) may be entering the most important phase of its AI story. Training grabbed the early spotlight, but inference could drive continuous demand across data centers. That creates a powerful setup for AMD, though the valuation now leaves little room for disappointment. Stock prices used were the market prices of May 29, … Read more
Marvell (NASDAQ:MRVL) has become a serious artificial intelligence infrastructure story as custom silicon, optical networking, and data center demand reshape its growth profile. The stock’s rally reflects rising confidence that hyperscalers need more efficient alternatives to general-purpose graphics processing units, but the valuation now forces investors to ask whether the upside still outweighs the risk. … Read more
Applied Digital (NASDAQ:APLD) has become one of the market’s most dramatic AI infrastructure stories after a massive rally and a new hyperscaler lease. The bullish thesis is simple but powerful: long-term contracted demand, scarce AI data center capacity, and a backlog that could support years of growth. The harder question is whether investors are already … Read more
Poet Technologies (NASDAQ:POET) is trying to move beyond its development-stage reputation and prove that its optical technology can serve the next wave of AI data centers. The Lumilens order has revived the bull case, but investors still have to weigh weak current revenue, dilution, and the pressure to scale production. Stock prices used were the … Read more
Meta (NASDAQ:META) faces one of the clearest investor dilemmas in big tech. The CapEx numbers look intimidating, but the company isn’t chasing AI without a business model. It’s embedding AI directly into advertising, where the money already flows and where even small improvements can create meaningful upside. Stock prices used were the market prices of … Read more
Hims & Hers Health (NYSE:HIMS) is facing one of the most important moments in its growth story. The stock has fallen sharply, margins are under pressure, and investors are questioning whether GLP-1 demand can become a durable profit engine. But subscriber growth, positive cash flow, and international expansion still leave room for a much bigger … Read more
SpaceX (NASDAQ:SPCX) is not just entering the public market as a rocket company. It is arriving with Starlink, Starship, AI infrastructure, defense exposure, and one of the most ambitious growth stories investors have seen in years. The bullish case is powerful, but the spending risk could force investors to separate excitement from actual returns. Stock … Read more
IonQ (NYSE:IONQ) is emerging as the clearest execution story in a quantum computing sector still filled with hype, losses, and uncertainty. D-Wave (NYSE: QBTS) has a compelling enterprise angle, while Rigetti (NASDAQ: RGTI) offers high-risk upside, but IonQ’s revenue growth and government relationships make this comparison much harder to ignore. Stock prices used were the … Read more
Microsoft (NASDAQ:MSFT) faces a familiar Wall Street dilemma: huge spending today for potential dominance tomorrow. The risk is real, but so is the opportunity. If Azure and Copilot keep gaining traction, Microsoft’s AI investment could strengthen one of the most durable enterprise technology ecosystems in the market. Stock prices used were the market prices of … Read more
You Found Me :)
Now Let's Grow Your Wealth
Learn to invest like the pros—even if you're just starting.
